ASH 2016 highlights: breaking new ground in haematology

ALL: Combining paediatric-type therapy with minimal residual disease

Vadastuximab talirine in combination for newly diagnosed AML

Gold nanoparticles and cancer treatment

Yeast cell cycle; what has this taught us?

Target mutations in lung cancer

New optimism for advanced breast cancer patients failing antiestrogens: Opening audience survey

Biology and function of CDKs

Clinical data on breast cancer trials

CDK 4/6 inhibitors: Management of side effects

What involvement do stem cells have in disease and resistance?

Using adoptive cell therapy to fight cancer